Thomas Catinazzo, Chief Financial Officer at Relay Therapeutics, Inc. (RLAY), sold 4,865 shares at $4.42 ($21K) on 2024-12-27, disclosed to the SEC on 2024-12-31.
Scheduled sale ($21k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.38 | 299 | $1K | 6.1% |
| 2 | $4.42 | 4,566 | $20K | 93.9% |
| Total | $4.42 avg | 4,865 | $21K | 100% |
| Filing → |
| RLAY | SELL | 2026-08-18 | $350K | — | Filing → |
| RLAY | SELL | 2026-07-30 | $27K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $331K | — | Filing → |